Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
Novo Nordisk(NVO) The Motley Fool·2024-03-15 14:15Danish pharmaceutical company Novo Nordisk (NVO -1.37%) has taken the world by storm thanks to its popular diabetes and obesity medications Ozempic, Rybelsus, and Wegovy.2023 was a milestone year for Novo Nordisk, with Ozempic and Wegovy playing lead roles in the company's growth. Just last week, Novo Nordisk received some positive news from the Food and Drug Administration (FDA), and the shares soared to new highs.Let's break down what's going on at Novo Nordisk and assess why the company's best days may b ...